Alinity i Toxo IgM
Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii. 510(k) K233932, from Abbott Laboratories (Abbott Park, IL). Product code LGD, class 2.
As of Nov 21, 2026, K233932 is an FDA 510(k) held by Abbott Laboratories, substantially equivalent on Aug 30, 2024 after 260 days, with no recalls tied to it in FDA's recall database.
- Review time: 260 days
- Recalls: 0
The Alinity i Toxo IgM assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to Toxoplasma gondii in human serum, serum separator, and plasma tubes (lithium heparin, lithium heparin separator, and tripotassium EDTA) on the Alinity i system.
- Vidas Toxoplasma Gondii Igm AsssayK923166 · Biomerieux Vitek, Inc. · Feb 25, 1993
- Access Toxo IgGK242022 · Beckman Coulter, Inc. · Mar 28, 2025
- Access Toxo IgM IIK242095 · Beckman Coulter, Inc. · Oct 11, 2024
- ARCHITECT Toxo IgGK210596 · Abbott Laboratories · May 19, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 14, 2023
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3780
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files